SCHEMBL30878341

SCHEMBL30878341

C=Cc1c(-c2c(Cl)cccc2Cl)c(=O)n(C)c2nc(Nc3ccc(N(C)CCN(C)C)cc3)ncc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 11/20 0.52
WEE1 P30291 7/20 0.49
SRC P12931 10/20 0.48
KCNH2 Q12809 1/20 0.48
PDGFRB P09619 8/20 0.47
PDGFRA P16234 8/20 0.47
ABL1 P00519 6/20 0.47
MAPK14 Q16539 6/20 0.47
EGFR P00533 4/20 0.47
RIPK2 O43353 2/20 0.47
ACVR1 Q04771 2/20 0.47
TNK2 Q07912 2/20 0.47
NOD2 Q9HC29 2/20 0.47
FGFR2 P21802 2/20 0.47
FGFR4 P22455 2/20 0.47
FGFR3 P22607 2/20 0.47
CHEK1 O14757 1/20 0.47
JAK2 O60674 1/20 0.47
PRKD3 O94806 1/20 0.47
MAP4K4 O95819 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30878332 0.92 WEE1 (0.56) FGFR1WEE1SRCKCNH2PDGFRB
SCHEMBL30878400 0.86 FGFR1 (0.53) FGFR1WEE1SRCKCNH2PDGFRB
SCHEMBL30878469 0.82 CCNT1 (0.46) WEE1KCNH2EGFRRIPK2ACVR1
SCHEMBL30879066 0.81 FGFR1 (0.48) FGFR1WEE1SRCKCNH2PDGFRB
SCHEMBL30878325 0.80 WEE1 (0.58) FGFR1WEE1SRCKCNH2PDGFRB
SCHEMBL30878382 0.80 WEE1 (0.70) FGFR1WEE1SRCPDGFRBPDGFRA
SCHEMBL30878448 0.79 ABL1 (0.68) FGFR1WEE1SRCPDGFRBPDGFRA
SCHEMBL30878380 0.77 WEE1 (0.48) FGFR1WEE1SRCKCNH2PDGFRB
SCHEMBL30878365 0.77 FGFR1 (0.47) FGFR1WEE1SRCKCNH2PDGFRB
SCHEMBL30878310 0.76 EGFR (0.65) FGFR1WEE1SRCPDGFRBPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 EP claimed
WO-2024094963-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-05-10 WO claimed
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 EP disclosed
WO-2024094963-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-05-10 WO disclosed